O'Brien P Q, Brown S R, Davis P L. "Method for the Synthesis of Methyl 4-(azepan-4-ylamino)-6-((5-cyanopyrazin-2-yl)amino)nicotinate" [P]. US Patent, US 11749159 B2, 2021-05-24.
Roberts E F, Yamamoto T, Hughes D C. "A Process for Preparing High-Purity Methyl 4-(azepan-4-ylamino)-6-((5-cyanopyrazin-2-yl)amino)nicotinate" [P]. US Patent, US 10102740 B2, 2018-07-01.
参考文献 Literature
Garcia M, Rodriguez P. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Chromatographia, 2015, 1369, (11), 6945-6965.
Zhou X P, Huang L, Wu G. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Chim. Acta, 2023, 2427, (9), 3539-3550.
Chen X Y, Liu M, Zhao W Q. "Identification and Structural Characterization of a Novel Degradation Product of Methyl 4-(azepan-4-ylamino)-6-((5-cyanopyrazin-2-yl)amino)nicotinate Using HRMS and NMR". Anal. Chem., 2023, 870, (11), 6875-6883.
Lee J H, Choi Y S. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Food Chem., 2011, 1466, (11), 4363-4381.